Greatbatch, Inc. Provides Preliminary Earnings Results for the Year Ended December 28, 2012; Provides Earnings Guidance for the Full Year of 2013
The company also provided earnings guidance for the year 2013. For the year, the company's total sales are expected to be in a range of $660 million to $680 million, an increase of 2% to 5% primarily driven by growth in the Portable Medical and Vascular product lines. Adjusted operating margin is targeted to be 12.0% to 12.5%. Adjusted diluted EPS growth is expected to be in the range of $1.90 to $2.00, an increase of 7% to 13%. Adjusted effective tax rate includes only the 2013 benefit of the recently reenacted R&D Tax Credit to be in a range of 33% to 35%.